(Q38701968)

5 September 2017

1 reference

title

Clinical issues in the use of carbamazepine in psychiatry: a review (English)

1 reference

5 September 2017

1 reference

Elphick M

1

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 August 1989

1 reference

5 September 2017

published in

Psychological Medicine

1 reference

5 September 2017

volume

19

1 reference

5 September 2017

issue

3

1 reference

5 September 2017

page(s)

591-604

1 reference

Carbamazepine and hyponatremia in patients with affective disorder

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Absence of carbamazepine-induced hyponatremia among patients also given lithium

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Lithium-carbamazepine neurotoxicity and risk factors

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Lithium and pregnancy. I. Report from the Register of Lithium Babies

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Antidepressant effects of carbamazepine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Episodic dyscontrol disorder and paroxysmal EEG abnormalities: successful treatment with carbamazepine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Water intoxication in epileptic patients receiving carbamazepine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Treatment of resistant lithium-induced nephrogenic diabetes insipidus and schizoaffective psychosis with carbamazepine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine in the psychiatric patient

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Adenosine antagonist properties of carbamazepine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Hematological effects of carbamazepine in patients with affective illness

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Effects of carbamazepine on plasma haloperidol levels

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Organic personality disturbance: a case of apparent atypical cyclic affective disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine and hematological monitoring

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine in manic-depressive illness: a new treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Potent therapeutic effect of carbamazepine-10,11-epoxide in trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Differential time course of antidepressant effects after sleep deprivation, ECT, and carbamazepine: clinical and theoretical implications.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

A haloperidol-carbamazepine interaction in a patient with rapid-cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Effects of carbamazepine on dopamine function in rodents

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine-induced orofacial dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine in treatment of violent schizophrenics

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Posttraumatic stress disorder in vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamazepine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Case report of a possible interaction between neuroleptics and carbamazepine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Correlates of antimanic response to carbamazepine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

The effect of carbamazepine and lithium on remission from affective illness

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Open clinical trial of carbamazepine in chronic schizophrenic inpatients.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine in the treatment of bulimia.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine and hyponatremia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine in the treatment of catatonia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Interaction between lithium and carbamazepine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Lack of pharmacokinetic interaction of carbamazepine with tranylcypromine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine treatment of selected affectively disordered inpatients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Effects of long-term carbamazepine treatment on water metabolism and plasma vasopressin concentration

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Specific and potent interactions of carbamazepine with brain adenosine receptors

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Relationship of response to sleep deprivation and carbamazepine in depressed patients.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Reversal of vanadate-induced inhibition of Na-K ATPase. A possible explanation of the therapeutic effect of carbamazepine in affective illness

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

The treatment of chronic depression. An illustrative case

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Combined carbamazepine and lithium therapy for violent behavior

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre doubl-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Hyponatremia during carbamazepine therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Carbamazepine Therapy Complicated by Nodal Bradycardia and Water Intoxication

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Preliminary study of carbamazepine in post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

How does adenosine inhibit transmitter release?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

An open clinical trial of carbamazepine in treatment-resistant bipolar and schizo-affective psychotics

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

Effects of carbamazepine on serum electrolytes in affectively ill patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700024193

7 January 2021

10.1017/S0033291700024193

Identifiers

DOI

0 references

1 reference